• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-588 通过靶向 GRN 抑制肺鳞癌细胞迁移和侵袭。

MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma.

机构信息

Department of Geriatrics, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, P.R. China.

出版信息

Mol Med Rep. 2016 Oct;14(4):3021-8. doi: 10.3892/mmr.2016.5643. Epub 2016 Aug 19.

DOI:10.3892/mmr.2016.5643
PMID:27571908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5042737/
Abstract

MicroRNAs (miRNAs) have been demonstrated to be critical in regulating tumor development and progression. The present study investigated the expression of miR‑588 using reverse transcription‑quantitative polymerase chain reaction analysis in 85 cases of lung squamous cell carcinoma (SCC), and observed the correlation between the expression of miR‑588 with clinical pathologic features. The results indicated that the expression of miR‑588 was predominantly lower in the tumor samples, compared with non‑tumorous samples, and was negatively associated with tumor stages and lymph node invasion. The present study also examined the significance of the expression of miR‑588 in SCC using gain‑ and loss‑of‑function analyses. It was found that miR‑588 inhibited tumor cell migration and invasion. In addition, it was revealed that the overexpression of miR‑588 in SCC cells reduced the mRNA and protein levels of progranulin (GRN), whereas miR‑588 silencing increased the expression of GRN. A luciferase activity assay showed that miR‑588 was able to directly bind to the 3'untranslated region of GRN and regulate its expression. Furthermore, it was found that the expression of GRN was inversely correlated with the expression of miR‑588 in 85 paired SCC samples. These results indicated that GRN was involved in the miR-588-mediated suppressive functions in the progression of SCC.

摘要

微小 RNA(miRNAs)已被证明在调节肿瘤的发生和发展中起着关键作用。本研究采用逆转录定量聚合酶链反应分析,检测了 85 例肺鳞癌(SCC)中 miR-588 的表达,并观察了 miR-588 的表达与临床病理特征之间的相关性。结果表明,miR-588 在肿瘤组织中的表达明显低于非肿瘤组织,且与肿瘤分期和淋巴结浸润呈负相关。本研究还通过增益和缺失功能分析,探讨了 miR-588 在 SCC 中的表达意义。结果表明,miR-588 抑制肿瘤细胞的迁移和侵袭。此外,还揭示了在 SCC 细胞中过表达 miR-588 可降低颗粒蛋白前体(GRN)的 mRNA 和蛋白水平,而 miR-588 沉默则增加了 GRN 的表达。荧光素酶活性测定表明,miR-588 可直接与 GRN 的 3'非翻译区结合,从而调节其表达。此外,还发现 85 对 SCC 样本中 GRN 的表达与 miR-588 的表达呈负相关。这些结果表明,GRN 参与了 miR-588 在 SCC 进展中介导的抑制功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/8fea5460df37/MMR-14-04-3021-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1cb582413bf2/MMR-14-04-3021-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/4b955d74b9cb/MMR-14-04-3021-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1b8759a790d2/MMR-14-04-3021-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1526da6ac4a7/MMR-14-04-3021-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/8fea5460df37/MMR-14-04-3021-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1cb582413bf2/MMR-14-04-3021-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/4b955d74b9cb/MMR-14-04-3021-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1b8759a790d2/MMR-14-04-3021-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/1526da6ac4a7/MMR-14-04-3021-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/5042737/8fea5460df37/MMR-14-04-3021-g04.jpg

相似文献

1
MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma.微小 RNA-588 通过靶向 GRN 抑制肺鳞癌细胞迁移和侵袭。
Mol Med Rep. 2016 Oct;14(4):3021-8. doi: 10.3892/mmr.2016.5643. Epub 2016 Aug 19.
2
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.抗肿瘤微小RNA-218对TPD52的调控抑制肺鳞状细胞癌的癌细胞迁移和侵袭。
Int J Oncol. 2016 Nov;49(5):1870-1880. doi: 10.3892/ijo.2016.3690. Epub 2016 Sep 13.
3
Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C.微小RNA-1/133a簇的下调通过调控冠蛋白1C增强肺鳞状细胞癌中癌细胞的迁移和侵袭。
J Hum Genet. 2015 Feb;60(2):53-61. doi: 10.1038/jhg.2014.111. Epub 2014 Dec 18.
4
Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.肿瘤抑制性微小RNA-29家族通过直接靶向肺鳞状细胞癌中的赖氨酰氧化酶样蛋白2(LOXL2)抑制癌细胞迁移和侵袭。
Int J Oncol. 2016 Feb;48(2):450-60. doi: 10.3892/ijo.2015.3289. Epub 2015 Dec 14.
5
Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.抑瘤 microRNA-133a 调控肺鳞癌中的新型分子网络。
J Hum Genet. 2012 Jan;57(1):38-45. doi: 10.1038/jhg.2011.126. Epub 2011 Nov 17.
6
Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.抑癌 microRNA-206 可同时抑制肺鳞癌细胞中的 MET 和 EGFR 致癌信号通路。
Int J Oncol. 2015 Mar;46(3):1039-50. doi: 10.3892/ijo.2014.2802. Epub 2014 Dec 18.
7
MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.microRNA-148a 通过下调胃癌中的 ROCK1 抑制肿瘤细胞侵袭和转移。
Clin Cancer Res. 2011 Dec 15;17(24):7574-83. doi: 10.1158/1078-0432.CCR-11-1714. Epub 2011 Oct 12.
8
MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.微小 RNA-101 通过直接靶向增强子结合锌指蛋白 2 在非小细胞肺癌中发挥肿瘤抑制功能。
J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.
9
MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.微小 RNA-218 通过靶向参与黏着斑通路的窖蛋白-2 抑制肾细胞癌中的细胞迁移和侵袭。
J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.
10
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.肺鳞状细胞癌肿瘤组织、癌旁组织及正常组织中微小RNA转录组的特征分析
J Thorac Cardiovasc Surg. 2015 May;149(5):1404-14.e4. doi: 10.1016/j.jtcvs.2015.02.012. Epub 2015 Feb 12.

引用本文的文献

1
Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening.利用机器学习和计算虚拟筛选确定肺鳞状细胞癌中与失巢凋亡相关生物标志物的潜在诊断靶点和治疗策略。
Front Pharmacol. 2025 Feb 14;16:1500968. doi: 10.3389/fphar.2025.1500968. eCollection 2025.
2
Analysis and exploration of regulatory mechanisms and potential prognostic biomarkers in squamous cell carcinoma of the lung by expression profiling.通过表达谱分析探索肺鳞状细胞癌的调控机制及潜在预后生物标志物
Transl Cancer Res. 2025 Jan 31;14(1):569-583. doi: 10.21037/tcr-2024-2443. Epub 2025 Jan 23.
3

本文引用的文献

1
Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.雌激素通过星形胶质细胞介导的旁分泌机制促进三阴性乳腺癌细胞的脑转移定植。
Oncogene. 2016 Jun 2;35(22):2881-92. doi: 10.1038/onc.2015.353. Epub 2015 Sep 28.
2
Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling.TRIM37的过表达通过激活Wnt/β-连环蛋白信号通路促进肝细胞癌的细胞迁移和转移。
Biochem Biophys Res Commun. 2015 Sep 4;464(4):1120-1127. doi: 10.1016/j.bbrc.2015.07.089. Epub 2015 Jul 21.
3
Significance of as a biomarker for clinical prognosis, immune infiltration, and drug therapy in lung squamous cell carcinoma.
在肺鳞状细胞癌中,作为临床预后、免疫浸润和药物治疗的生物标志物的意义。
PeerJ. 2024 May 1;12:e17338. doi: 10.7717/peerj.17338. eCollection 2024.
4
Tumor microenvironment characteristics and prognostic role of mA modification in lung squamous cell carcinoma.肺鳞状细胞癌中 mA 修饰的肿瘤微环境特征及预后作用
Heliyon. 2024 Feb 28;10(5):e26851. doi: 10.1016/j.heliyon.2024.e26851. eCollection 2024 Mar 15.
5
Establishment of a prognostic model toward lung squamous cell carcinoma based on mG-related genes in the cancer genome atlas.基于癌症基因组图谱中 mG 相关基因建立肺鳞癌预后模型。
Physiol Genomics. 2023 Oct 1;55(10):427-439. doi: 10.1152/physiolgenomics.00149.2022. Epub 2023 Aug 14.
6
MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines.微小RNA-101-3p靶向核转运蛋白α2以抑制肺鳞癌细胞系的进展。
Histol Histopathol. 2023 Oct;38(10):1169-1178. doi: 10.14670/HH-18-573. Epub 2022 Dec 13.
7
Circ_0010235 Regulates HOXA10 Expression to Promote Malignant Phenotypes and Radioresistance in Non-small Cell Lung Cancer Cells Via Decoying miR-588.环状 RNA 0010235 通过诱饵 miR-588 调控 HOXA10 表达促进非小细胞肺癌细胞的恶性表型和放射抵抗
Balkan Med J. 2022 Jul 22;39(4):255-266. doi: 10.4274/balkanmedj.galenos.2022.2022-2-50.
8
-Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR.N6-甲基腺苷相关长链非编码RNA被鉴定为肺鳞状细胞癌潜在的预后生物标志物并通过实时聚合酶链反应验证。
Front Genet. 2022 Jun 3;13:839957. doi: 10.3389/fgene.2022.839957. eCollection 2022.
9
LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588/ROCK1 axis.长链非编码RNA ZFAS1通过miR-588/ROCK1轴调节高糖诱导的人肾小球系膜细胞的增殖、氧化应激、纤维化和炎症。
Diabetol Metab Syndr. 2022 Jan 28;14(1):21. doi: 10.1186/s13098-022-00791-3.
10
Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.血浆 circN4BP2L2 是一种有前途的上皮性卵巢癌新型诊断生物标志物。
BMC Cancer. 2022 Jan 3;22(1):6. doi: 10.1186/s12885-021-09073-z.
MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
微小RNA-15a通过靶向非小细胞肺癌中的BCL2L2诱导细胞凋亡并抑制转移。
Tumour Biol. 2015 Jun;36(6):4357-65. doi: 10.1007/s13277-015-3075-1. Epub 2015 Jan 22.
4
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.微小RNA作为癌细胞与肿瘤微环境之间的介质和沟通者。
Oncogene. 2015 Nov 26;34(48):5857-68. doi: 10.1038/onc.2015.89. Epub 2015 Apr 13.
5
Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.单核细胞趋化蛋白-1促进骨肉瘤细胞的增殖和侵袭,并上调AKT的表达。
Mol Med Rep. 2015 Jul;12(1):219-25. doi: 10.3892/mmr.2015.3375. Epub 2015 Feb 18.
6
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.早期肺腺癌患者五年死亡风险分子与病理模型的验证
J Thorac Oncol. 2015 Jan;10(1):67-73. doi: 10.1097/JTO.0000000000000365.
7
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.GP88(颗粒蛋白前体):一种用于非小细胞肺癌的新型组织及循环生物标志物。
Hum Pathol. 2014 Sep;45(9):1893-9. doi: 10.1016/j.humpath.2014.05.011. Epub 2014 Jun 5.
8
miR-339-5p inhibits cell migration and invasion and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer.微小RNA-339-5p抑制细胞迁移和侵袭,可能与非小细胞肺癌的肿瘤-淋巴结-转移分期及淋巴结转移相关。
Oncol Lett. 2014 Aug;8(2):719-725. doi: 10.3892/ol.2014.2165. Epub 2014 May 22.
9
Blocking the PI3K pathway enhances the efficacy of ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung cancer.阻断PI3K信号通路可增强EML4-ALK阳性非小细胞肺癌中ALK靶向治疗的疗效。
Tumour Biol. 2014 Oct;35(10):9759-67. doi: 10.1007/s13277-014-2252-y. Epub 2014 Jun 29.
10
Cancer treatment and survivorship statistics, 2014.癌症治疗和生存统计,2014 年。
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71. doi: 10.3322/caac.21235. Epub 2014 Jun 1.